Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336700
Status:
TERMINATED
Last Update Posted:
2016-09-19
First Post:
2006-06-12
Brief Title:
A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer
Sponsor:
Organization:
University of Pittsburgh